Table 3: Responses to Phase II of the Survey .

SymptomMale
(total), %
Female
(total), %
Total
(total), %
value

Oral cavity bleeding144 (296), 48.6134 (229), 58.5278 (525), 52.90.028
Epistaxis147 (296), 49.782 (229), 35.8229 (525), 43.60.002
Cutaneous symptoms52 (296), 17.6102 (229), 44.5154 (525), 29.3<0.001
Menstrual bleedingNot applicable56 (229), 24.556 (229), 24.5-
Minor wound bleeding39 (296), 13.256 (229), 24.595 (525), 18.10.001
Bleeding during tooth extraction25 (296), 8.442 (229), 18.367 (525), 12.80.001
Gastrointestinal bleeding15 (296), 5.131 (229), 13.546 (525), 8.80.001
Muscle hematoma and hemarthrosis24 (525), 4.6
Spontaneous bleeding3 (14), 21.46 (10), 609 (24), 37.50.092

Values are reported as (N), %.